Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In Reply.
Fay KE, Bartz D. Fay KE, et al. Obstet Gynecol. 2023 Feb 1;141(2):420. doi: 10.1097/AOG.0000000000005065. Obstet Gynecol. 2023. PMID: 36657147 No abstract available.
Factors Affecting Willingness to Provide Medication Abortion Among North American Society for Pediatric and Adolescent Gynecology Members Caring for Adolescents and Young Adults Following the Dobbs Decision.
Bryson AE, Boskey ER, Grubb LK, Shim JY, Fay KE. Bryson AE, et al. Among authors: fay ke. J Pediatr Adolesc Gynecol. 2024 Dec;37(6):586-594. doi: 10.1016/j.jpag.2024.07.013. Epub 2024 Aug 5. J Pediatr Adolesc Gynecol. 2024. PMID: 39111689 Free article.
Toxicities of herbal abortifacients.
Feng C, Fay KE, Burns MM. Feng C, et al. Am J Emerg Med. 2023 Jun;68:42-46. doi: 10.1016/j.ajem.2023.03.005. Epub 2023 Mar 7. Am J Emerg Med. 2023. PMID: 36924751 Free PMC article. Review.
Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas.
Chong EA, Penuel E, Napier EB, Lundberg RK, Budde LE, Shadman M, Matasar MJ, Bartlett NL, Flinn IW, Bosch F, Fay K, Goy A, Kumar A, Nastoupil LJ, Wei MC, Wu M, Yin S, Fraietta JA, Chong ER, Schuster SJ. Chong EA, et al. Among authors: fay k. Blood Adv. 2024 Nov 21:bloodadvances.2024013640. doi: 10.1182/bloodadvances.2024013640. Online ahead of print. Blood Adv. 2024. PMID: 39571171
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.
Sehn LH, Bartlett NL, Matasar MJ, Schuster SJ, Assouline SE, Giri P, Kuruvilla J, Shadman M, Cheah CY, Dietrich S, Fay K, Ku M, Nastoupil LJ, Wei MC, Yin S, To I, Kaufman D, Kwan A, Penuel E, Bolen CR, Budde LE. Sehn LH, et al. Among authors: fay k. Blood. 2024 Oct 24:blood.2024025454. doi: 10.1182/blood.2024025454. Online ahead of print. Blood. 2024. PMID: 39447094
216 results